United States Biotechnology & Medical Research

Allos Therapeutics Inc (ALTH)

Track

Track

Ticker: ALTH Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
SPECTRUM PHARMACEUTICALS INC Large shareholder
Transaction date
Purchase
Price
475.70
Quantity 57,126 +34.3%
Value US$4,477,801
BENNETT BRUCE K JR VP, Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
198.88
Quantity 8,268 -11.5%
Value US$3,779,526
BENNETT BRUCE K JR VP, Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
75.81
Quantity 41,087 +32.2%
Value US$4,606,948
BENNETT BRUCE K JR VP, Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
1.55
Quantity 1,469 -1.3%
Value US$2,277
BENNETT BRUCE K JR VP, Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
3.20
Quantity 1,469 -1.5%
Value US$4,701
Clark David C VP, Finance Officer
Transaction date
Planned sale
Price
7.03
Quantity 3,085 -15.3%
Value US$21,684
Graboyes Marc H SVP, General Counsel Officer
Transaction date
Planned sale
Price
8.58
Quantity 75,000 -56.4%
Value US$643,530
Clark David C VP, Finance Officer
Transaction date
Planned sale
Price
7.78
Quantity 20,000 -50.8%
Value US$155,612
Clark David C VP, Finance Officer
Transaction date
Planned sale
Price
7.02
Quantity 10,000 -34.1%
Value US$70,196
Clark David C VP, Finance Officer
Transaction date
Planned sale
Price
6.98
Quantity 11,640 -37.6%
Value US$81,301
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
8.13
Quantity 37,500 -26.6%
Value US$304,875
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
8.13
Quantity 40,000 -22.1%
Value US$325,204
BERNS PAUL L Chief Executive Officer Officer
Transaction date
Planned sale
Price
7.57
Quantity 7,362 -3.2%
Value US$55,766
Graboyes Marc H SVP, General Counsel Officer
Transaction date
Planned sale
Price
7.44
Quantity 2,349 -3.9%
Value US$17,477
BERNS PAUL L Chief Executive Officer Officer
Transaction date
Planned sale
Price
7.51
Quantity 4,304 -1.8%
Value US$32,331
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
7.44
Quantity 5,968 -4.1%
Value US$44,378
Graboyes Marc H SVP, General Counsel Officer
Transaction date
Planned sale
Price
7.51
Quantity 1,416 -2.3%
Value US$10,634
BENNETT BRUCE K JR VP, Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
7.51
Quantity 1,468 -6.0%
Value US$11,025
HOFFMAN STEPHEN J Non-Executive Director
Transaction date
Planned sale
Price
7.30
Quantity 45,428 -8.7%
Value US$331,738
HOFFMAN STEPHEN J Non-Executive Director
Transaction date
Planned sale
Price
7.11
Quantity 45,429 -8.7%
Value US$322,918
HOFFMAN STEPHEN J Non-Executive Director
Transaction date
Planned sale
Price
6.76
Quantity 45,429 -8.7%
Value US$307,114
HOFFMAN STEPHEN J Non-Executive Director
Transaction date
Planned sale
Price
6.78
Quantity 45,429 -8.7%
Value US$308,163
HOFFMAN STEPHEN J Non-Executive Director
Transaction date
Planned sale
Price
6.64
Quantity 45,428 -8.7%
Value US$301,497
HOFFMAN STEPHEN J Non-Executive Director
Transaction date
Planned sale
Price
6.54
Quantity 25,428 -5.1%
Value US$166,220
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
8.13
Quantity 85,400 -49.0%
Value US$694,302
BERNS PAUL L Chief Executive Officer Officer
Transaction date
Planned sale
Price
8.24
Quantity 342,000 -59.6%
Value US$2,819,311
BERNS PAUL L Chief Executive Officer Officer
Transaction date
Planned sale
Price
8.14
Quantity 8,000 -3.3%
Value US$65,150
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
8.13
Quantity 14,600 -14.1%
Value US$118,755
Graboyes Marc H VP, General Counsel Officer
Transaction date
Planned sale
Price
8.00
Quantity 50,000 -71.4%
Value US$400,000
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
7.79
Quantity 50,000 -36.0%
Value US$389,480
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
7.37
Quantity 39,500 -25.3%
Value US$291,206
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
7.13
Quantity 6,900 -5.6%
Value US$49,209
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
7.13
Quantity 3,600 -3.0%
Value US$25,674
Clark David C VP, Finance Officer
Transaction date
Planned sale
Price
7.00
Quantity 5,027 -41.3%
Value US$35,189
Graboyes Marc H VP, General Counsel Officer
Transaction date
Planned sale
Price
7.00
Quantity 5,864 -22.6%
Value US$41,048
Clark David C VP, Finance Officer
Transaction date
Planned sale
Price
7.02
Quantity 64,973 -90.1%
Value US$455,812
CARUSO JAMES V Chief Commercial Officer Officer
Transaction date
Planned sale
Price
7.13
Quantity 50,000 -30.1%
Value US$356,500
Graboyes Marc H VP, General Counsel Officer
Transaction date
Planned sale
Price
7.02
Quantity 69,136 -77.5%
Value US$485,010
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.26
Quantity 22 -0.0%
Value US$182
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 24,857 -11.5%
Value US$203,176
BAKER JULIAN Large shareholder
Transaction date
Sale
Price
8.26
Quantity 1 -0.0%
Value US$8
BAKER JULIAN Large shareholder
Transaction date
Sale
Price
8.17
Quantity 705 -11.5%
Value US$5,763
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.26
Quantity 235 -0.0%
Value US$1,940
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 263,312 -11.5%
Value US$2,152,260
Baker Bros. Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 212 -11.5%
Value US$1,733
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.26
Quantity 8 -0.0%
Value US$66
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 9,380 -11.5%
Value US$76,670
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.26
Quantity 670 -0.0%
Value US$5,532
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 751,534 -11.5%
Value US$6,142,889
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.11
Quantity 4,725 -2.1%
Value US$38,299
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 1,200 -0.5%
Value US$9,806
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.16
Quantity 6,392 -2.8%
Value US$52,180
BAKER JULIAN Large shareholder
Transaction date
Sale
Price
8.11
Quantity 134 -2.1%
Value US$1,086
BAKER JULIAN Large shareholder
Transaction date
Sale
Price
8.17
Quantity 34 -0.5%
Value US$278
BAKER JULIAN Large shareholder
Transaction date
Sale
Price
8.16
Quantity 181 -2.8%
Value US$1,478
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.11
Quantity 50,041 -2.1%
Value US$405,617
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 12,713 -0.5%
Value US$103,882
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.16
Quantity 67,709 -2.8%
Value US$552,729
Baker Bros. Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.11
Quantity 40 -2.1%
Value US$324
Baker Bros. Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 10 -0.5%
Value US$82
Baker Bros. Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.16
Quantity 55 -2.8%
Value US$449
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.11
Quantity 1,782 -2.1%
Value US$14,444
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 453 -0.5%
Value US$3,702
Baker / Tisch Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.16
Quantity 2,411 -2.8%
Value US$19,682
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.11
Quantity 142,827 -2.1%
Value US$1,157,713
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.17
Quantity 36,286 -0.5%
Value US$296,504
Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.16
Quantity 193,252 -2.8%
Value US$1,577,574
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.46
Quantity 24,256 -9.6%
Value US$205,191
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.47
Quantity 2,593 -1.0%
Value US$21,961
14159 capital (GP), LLC Large shareholder
Transaction date
Sale
Price
9.03
Quantity 269 -0.1%
Value US$2,430
BAKER JULIAN Large shareholder
Transaction date
Sale
Price
8.46
Quantity 688 -9.6%
Value US$5,820
BAKER JULIAN Large shareholder
Transaction date
Sale
Price
8.47
Quantity 74 -1.0%
Value US$627
BAKER JULIAN Large shareholder
Transaction date
Sale
Price
9.03
Quantity 8 -0.1%
Value US$72
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.46
Quantity 256,936 -9.6%
Value US$2,173,524
Baker Biotech Capital (GP), LLC Large shareholder
Transaction date
Sale
Price
8.47
Quantity 27,485 -1.1%
Value US$232,781
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2012-09-06 2012-09-05 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
57,126 +34.3%
475.70
US$4,477,801 		57,126 +34.3% 475.70 US$4,477,801
2012-03-01 2012-03-01 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
8,268 -11.5%
198.88
US$3,779,526 		8,268 -11.5% 198.88 US$3,779,526
2012-03-01 2012-02-29 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
41,087 +32.2%
75.81
US$4,606,948 		41,087 +32.2% 75.81 US$4,606,948
2012-02-27 2012-02-24 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
1,469 -1.3%
1.55
US$2,277 		1,469 -1.3% 1.55 US$2,277
2011-02-25 2011-02-24 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
1,469 -1.5%
3.20
US$4,701 		1,469 -1.5% 3.20 US$4,701
2010-05-12 2010-05-10 PlS Planned sale Clark David C

VP, Finance

Officer
3,085 -15.3%
7.03
US$21,684 		3,085 -15.3% 7.03 US$21,684
2010-04-14 2010-04-12 PlS Planned sale Graboyes Marc H

SVP, General Counsel

Officer
75,000 -56.4%
8.58
US$643,530 		75,000 -56.4% 8.58 US$643,530
2010-03-12 2010-03-10 PlS Planned sale Clark David C

VP, Finance

Officer
20,000 -50.8%
7.78
US$155,612 		20,000 -50.8% 7.78 US$155,612
2010-03-08 2010-03-05 PlS Planned sale Clark David C

VP, Finance

Officer
10,000 -34.1%
7.02
US$70,196 		10,000 -34.1% 7.02 US$70,196
2010-03-08 2010-03-04 PlS Planned sale Clark David C

VP, Finance

Officer
11,640 -37.6%
6.98
US$81,301 		11,640 -37.6% 6.98 US$81,301
2010-03-03 2010-03-01 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
37,500 -26.6%
8.13
US$304,875 		37,500 -26.6% 8.13 US$304,875
2010-03-03 2010-03-01 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
40,000 -22.1%
8.13
US$325,204 		40,000 -22.1% 8.13 US$325,204
2010-02-24 2010-02-24 PlS Planned sale BERNS PAUL L

Chief Executive Officer

Officer
7,362 -3.2%
7.57
US$55,766 		7,362 -3.2% 7.57 US$55,766
2010-02-24 2010-02-24 PlS Planned sale Graboyes Marc H

SVP, General Counsel

Officer
2,349 -3.9%
7.44
US$17,477 		2,349 -3.9% 7.44 US$17,477
2010-02-24 2010-02-23 PlS Planned sale BERNS PAUL L

Chief Executive Officer

Officer
4,304 -1.8%
7.51
US$32,331 		4,304 -1.8% 7.51 US$32,331
2010-02-24 2010-02-23 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
5,968 -4.1%
7.44
US$44,378 		5,968 -4.1% 7.44 US$44,378
2010-02-24 2010-02-23 PlS Planned sale Graboyes Marc H

SVP, General Counsel

Officer
1,416 -2.3%
7.51
US$10,634 		1,416 -2.3% 7.51 US$10,634
2010-02-24 2010-02-23 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
1,468 -6.0%
7.51
US$11,025 		1,468 -6.0% 7.51 US$11,025
2010-01-11 2010-01-11 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,428 -8.7%
7.30
US$331,738 		45,428 -8.7% 7.30 US$331,738
2010-01-11 2010-01-08 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,429 -8.7%
7.11
US$322,918 		45,429 -8.7% 7.11 US$322,918
2010-01-11 2010-01-07 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,429 -8.7%
6.76
US$307,114 		45,429 -8.7% 6.76 US$307,114
2010-01-06 2010-01-06 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,429 -8.7%
6.78
US$308,163 		45,429 -8.7% 6.78 US$308,163
2010-01-06 2010-01-05 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,428 -8.7%
6.64
US$301,497 		45,428 -8.7% 6.64 US$301,497
2010-01-06 2010-01-04 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
25,428 -5.1%
6.54
US$166,220 		25,428 -5.1% 6.54 US$166,220
2009-08-12 2009-08-10 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
85,400 -49.0%
8.13
US$694,302 		85,400 -49.0% 8.13 US$694,302
2009-08-12 2009-08-10 PlS Planned sale BERNS PAUL L

Chief Executive Officer

Officer
342,000 -59.6%
8.24
US$2,819,311 		342,000 -59.6% 8.24 US$2,819,311
2009-08-07 2009-08-05 PlS Planned sale BERNS PAUL L

Chief Executive Officer

Officer
8,000 -3.3%
8.14
US$65,150 		8,000 -3.3% 8.14 US$65,150
2009-08-05 2009-08-05 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
14,600 -14.1%
8.13
US$118,755 		14,600 -14.1% 8.13 US$118,755
2009-08-05 2009-08-03 PlS Planned sale Graboyes Marc H

VP, General Counsel

Officer
50,000 -71.4%
8.00
US$400,000 		50,000 -71.4% 8.00 US$400,000
2009-08-05 2009-08-03 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
50,000 -36.0%
7.79
US$389,480 		50,000 -36.0% 7.79 US$389,480
2009-03-27 2009-03-26 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
39,500 -25.3%
7.37
US$291,206 		39,500 -25.3% 7.37 US$291,206
2009-03-27 2009-03-25 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
6,900 -5.6%
7.13
US$49,209 		6,900 -5.6% 7.13 US$49,209
2009-03-16 2009-03-16 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
3,600 -3.0%
7.13
US$25,674 		3,600 -3.0% 7.13 US$25,674
2009-03-16 2009-03-13 PlS Planned sale Clark David C

VP, Finance

Officer
5,027 -41.3%
7.00
US$35,189 		5,027 -41.3% 7.00 US$35,189
2009-03-16 2009-03-13 PlS Planned sale Graboyes Marc H

VP, General Counsel

Officer
5,864 -22.6%
7.00
US$41,048 		5,864 -22.6% 7.00 US$41,048
2009-03-16 2009-03-12 PlS Planned sale Clark David C

VP, Finance

Officer
64,973 -90.1%
7.02
US$455,812 		64,973 -90.1% 7.02 US$455,812
2009-03-16 2009-03-12 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
50,000 -30.1%
7.13
US$356,500 		50,000 -30.1% 7.13 US$356,500
2009-03-16 2009-03-12 PlS Planned sale Graboyes Marc H

VP, General Counsel

Officer
69,136 -77.5%
7.02
US$485,010 		69,136 -77.5% 7.02 US$485,010
2009-02-06 2009-02-06 S Sale 14159 capital (GP), LLC Large shareholder
22 -0.0%
8.26
US$182 		22 -0.0% 8.26 US$182
2009-02-06 2009-02-06 S Sale 14159 capital (GP), LLC Large shareholder
24,857 -11.5%
8.17
US$203,176 		24,857 -11.5% 8.17 US$203,176
2009-02-06 2009-02-06 S Sale BAKER JULIAN Large shareholder
1 -0.0%
8.26
US$8 		1 -0.0% 8.26 US$8
2009-02-06 2009-02-06 S Sale BAKER JULIAN Large shareholder
705 -11.5%
8.17
US$5,763 		705 -11.5% 8.17 US$5,763
2009-02-06 2009-02-06 S Sale Baker Biotech Capital (GP), LLC Large shareholder
235 -0.0%
8.26
US$1,940 		235 -0.0% 8.26 US$1,940
2009-02-06 2009-02-06 S Sale Baker Biotech Capital (GP), LLC Large shareholder
263,312 -11.5%
8.17
US$2,152,260 		263,312 -11.5% 8.17 US$2,152,260
2009-02-06 2009-02-06 S Sale Baker Bros. Capital (GP), LLC Large shareholder
212 -11.5%
8.17
US$1,733 		212 -11.5% 8.17 US$1,733
2009-02-06 2009-02-06 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
8 -0.0%
8.26
US$66 		8 -0.0% 8.26 US$66
2009-02-06 2009-02-06 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
9,380 -11.5%
8.17
US$76,670 		9,380 -11.5% 8.17 US$76,670
2009-02-06 2009-02-06 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
670 -0.0%
8.26
US$5,532 		670 -0.0% 8.26 US$5,532
2009-02-06 2009-02-06 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
751,534 -11.5%
8.17
US$6,142,889 		751,534 -11.5% 8.17 US$6,142,889
2009-02-06 2009-02-05 S Sale 14159 capital (GP), LLC Large shareholder
4,725 -2.1%
8.11
US$38,299 		4,725 -2.1% 8.11 US$38,299
2009-02-06 2009-02-05 S Sale 14159 capital (GP), LLC Large shareholder
1,200 -0.5%
8.17
US$9,806 		1,200 -0.5% 8.17 US$9,806
2009-02-06 2009-02-05 S Sale 14159 capital (GP), LLC Large shareholder
6,392 -2.8%
8.16
US$52,180 		6,392 -2.8% 8.16 US$52,180
2009-02-06 2009-02-05 S Sale BAKER JULIAN Large shareholder
134 -2.1%
8.11
US$1,086 		134 -2.1% 8.11 US$1,086
2009-02-06 2009-02-05 S Sale BAKER JULIAN Large shareholder
34 -0.5%
8.17
US$278 		34 -0.5% 8.17 US$278
2009-02-06 2009-02-05 S Sale BAKER JULIAN Large shareholder
181 -2.8%
8.16
US$1,478 		181 -2.8% 8.16 US$1,478
2009-02-06 2009-02-05 S Sale Baker Biotech Capital (GP), LLC Large shareholder
50,041 -2.1%
8.11
US$405,617 		50,041 -2.1% 8.11 US$405,617
2009-02-06 2009-02-05 S Sale Baker Biotech Capital (GP), LLC Large shareholder
12,713 -0.5%
8.17
US$103,882 		12,713 -0.5% 8.17 US$103,882
2009-02-06 2009-02-05 S Sale Baker Biotech Capital (GP), LLC Large shareholder
67,709 -2.8%
8.16
US$552,729 		67,709 -2.8% 8.16 US$552,729
2009-02-06 2009-02-05 S Sale Baker Bros. Capital (GP), LLC Large shareholder
40 -2.1%
8.11
US$324 		40 -2.1% 8.11 US$324
2009-02-06 2009-02-05 S Sale Baker Bros. Capital (GP), LLC Large shareholder
10 -0.5%
8.17
US$82 		10 -0.5% 8.17 US$82
2009-02-06 2009-02-05 S Sale Baker Bros. Capital (GP), LLC Large shareholder
55 -2.8%
8.16
US$449 		55 -2.8% 8.16 US$449
2009-02-06 2009-02-05 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
1,782 -2.1%
8.11
US$14,444 		1,782 -2.1% 8.11 US$14,444
2009-02-06 2009-02-05 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
453 -0.5%
8.17
US$3,702 		453 -0.5% 8.17 US$3,702
2009-02-06 2009-02-05 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
2,411 -2.8%
8.16
US$19,682 		2,411 -2.8% 8.16 US$19,682
2009-02-06 2009-02-05 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
142,827 -2.1%
8.11
US$1,157,713 		142,827 -2.1% 8.11 US$1,157,713
2009-02-06 2009-02-05 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
36,286 -0.5%
8.17
US$296,504 		36,286 -0.5% 8.17 US$296,504
2009-02-06 2009-02-05 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
193,252 -2.8%
8.16
US$1,577,574 		193,252 -2.8% 8.16 US$1,577,574
2009-02-06 2009-02-04 S Sale 14159 capital (GP), LLC Large shareholder
24,256 -9.6%
8.46
US$205,191 		24,256 -9.6% 8.46 US$205,191
2009-02-06 2009-02-04 S Sale 14159 capital (GP), LLC Large shareholder
2,593 -1.0%
8.47
US$21,961 		2,593 -1.0% 8.47 US$21,961
2009-02-06 2009-02-04 S Sale 14159 capital (GP), LLC Large shareholder
269 -0.1%
9.03
US$2,430 		269 -0.1% 9.03 US$2,430
2009-02-06 2009-02-04 S Sale BAKER JULIAN Large shareholder
688 -9.6%
8.46
US$5,820 		688 -9.6% 8.46 US$5,820
2009-02-06 2009-02-04 S Sale BAKER JULIAN Large shareholder
74 -1.0%
8.47
US$627 		74 -1.0% 8.47 US$627
2009-02-06 2009-02-04 S Sale BAKER JULIAN Large shareholder
8 -0.1%
9.03
US$72 		8 -0.1% 9.03 US$72
2009-02-06 2009-02-04 S Sale Baker Biotech Capital (GP), LLC Large shareholder
256,936 -9.6%
8.46
US$2,173,524 		256,936 -9.6% 8.46 US$2,173,524
2009-02-06 2009-02-04 S Sale Baker Biotech Capital (GP), LLC Large shareholder
27,485 -1.1%
8.47
US$232,781 		27,485 -1.1% 8.47 US$232,781
Explore more

More insider trading research around Allos Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America